XML 45 R28.htm IDEA: XBRL DOCUMENT v3.4.0.3
Pro Forma Information – Vitro Acquisition
 12 Months Ended
Dec. 31, 2015
Pro Forma Information – Vitro Acquisition  
Pro Forma Information – Vitro Acquisition

20.  Pro Forma Information – Vitro Acquisition

Had the Vitro Acquisition, described in Note 19 and the related financing described in Note 11, occurred at the beginning of each respective period, unaudited pro forma consolidated net sales, earnings from continuing operations and earnings from continuing operations per share of common stock (diluted) would have been as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2015

 

 

 

As

 

 

 

 

 

 

 

Pro Forma

 

 

    

Reported

    

Acquisition

    

Financing

    

As Adjusted

 

 

 

(restated(1))

 

Adjustments

 

Adjustments

 

(restated(1))

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$
6,156

 

$
574

 

$

 —

 

$
6,730

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings from continuing operations attributable to the Company

 

$
139

 

$
75

 

$
(46)

 

$
168

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share from continuing operations

 

$
0.85

 

 

 

 

 

 

 

$
1.04

 

 

(1)

See Note 1 for restatement information.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2014

 

 

 

As

 

 

 

 

 

 

 

Pro Forma

 

 

    

Reported

    

Acquisition

    

Financing

    

As Adjusted

 

 

 

(restated(1))

 

Adjustments

 

Adjustments

 

(restated(1))

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$
6,784

 

$
858

 

$

 —

 

$
7,642

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings from continuing operations attributable to the Company

 

$
187

 

$
70

 

$
(71)

 

$
186

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share from continuing operations

 

$
1.13

 

 

 

 

 

 

 

$
1.12

 

See Note 1 for restatement information.